Publication | Closed Access
GL-V9 exerts anti-T cell malignancies effects via promoting lysosome-dependent AKT1 degradation and activating AKT1/FOXO3A/BIM axis
20
Citations
43
References
2019
Year
Cancer ImmunosurveillanceGl-v9 ExertsImmunologyImmune Checkpoint InhibitorAkt1/foxo3a/bim AxisAdult T-cell Leukemia-lymphomaImmunotherapyMedicineCell BiologyCell SignalingCancer ResearchLysosome-dependent Akt1 Degradation
| Year | Citations | |
|---|---|---|
Page 1
Page 1